Local Anesthesia and Tuberculin Skin Test in Infants and Children
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00309673
Recruitment Status : Unknown
Verified March 2006 by Assistance Publique - Hôpitaux de Paris. Recruitment status was: Not yet recruiting
The use of local anaesthesia efficiently reduces pain due to needle puncture. However, when tuberculin skin test is performed it is the skin reaction to tuberculin injection that is studied. It is a quantitative skin reaction measured in millimiters. From the study of literature it is not known whether local anaesthetic modify skin reaction to tuberculin. Therefore, before recommending the use local anaesthesia for tuberculin intradermal injection we have to rule out a potential effect of local anaesthetic on the result of the test. This is particularly important in children, since there are more sensitive to pain than adults
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
1 Month to 15 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
hospitalized or non hospitalized infant or child (3 months-15 years)requiring a tuberculin skin test, in our hospital. hospitalized 1 to 3 months old infants requiring a tuberculin skin test, in our hospital.
child with contra indication to the use of Lidocaine / prilocaine
child with evolutive dermatitis on forearms
premature or newborn (less than 1 month of age)
infants (1 - 24 months of age)who has yet received repeated local anaesthesia (at least 2)during the 24 previous hours
infants (1 - 24 months of age)who is treated with a drug that could enhance the risk of methhaemoglobinemia
child with previous evere local reaction to tuberculin injection (necrosis,ulceration)
child with history of tuberculosis disease
child with hepatic failure
parents or the child himself if lod enough, have not given their agreement for the study
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action